Inactive Instrument

New You, Inc. Stock

NWYU

US6501491079

New You, Inc., through its wholly owned subsidiary, New You LLC, markets and sells its products through a multi-level marketing and direct sales opportunity to independent business owners called 'Brand Partners.' The Company is engaged in marketing cannabidiol (CBD) products, which include CBD beverage enhancers that can be added to any beverage, CBD infused coffee, and CBD oil tinctures. Its product consists of Primus Skin Care and Infinite. Primus Skin Care develops products designed to combine anti-inflammatory benefits of CBD with different skin-enhancing properties of existing ingredients, such as hyaluronic acid, marshmallow root, immortelle oil. Infinite is a CBD manufacturer of isolate-based products, such as oils, gummies, capsules, creams and men's self-care products differentiated by its use of nanoparticles to improve products performance. It also produces and sells bulk nano products for use by third parties. It is also developing a synthetic CBD-based sugar alternative.

Employees

Sector

Pharmaceuticals

More about the company

Stock Market
Stocks
NWYU Stock

The best tools reserved for subscribers to boost the performance of your investments!

25-06-16	REIC Holdings, Inc. cancelled the transaction announced on June 17, 2024	CI
24-08-11	REIC Holdings, Inc. announced that it expects to receive $20 million in funding	CI
24-07-02	REIC Holdings, Inc. announced that it expects to receive $20 million in funding	CI
24-06-16	New You, Inc. announced a financing transaction	CI
21-10-08	Jason Frankovich Resigns from Position as Executive Chairman and as A Member of New You Inc. Board of Directors	CI
21-09-17	New You Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	CI
21-06-17	New You Inc. Appoints John Driscoll as Chief Financial Officer	CI
21-06-17	New You, Inc. Appoints John Driscoll as Member of Board of Directors	CI
21-05-24	New You Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	CI
21-05-12	New You Inc. Appoints Jason Frankovich as Executive Chairman	CI
21-05-06	New You Inc. acquired ST Brands, Inc.	CI
21-04-08	New You Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	CI
20-12-08	New You Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	CI

22-12-07	Author Dr. Rhonda Smith, ND, BCALP’s New Book, "Divine Core Transformation," is Aimed at Helping Readers Rethink & Heal from Their Addictive Relationships & Trauma	AQ
21-10-08	NEW YOU, INC. : Change in Directors or Principal Officers (form 8-K)	AQ
21-09-22	NEW YOU : Financial Statements and Exhibits (form 8-K/A)	AQ
21-09-20	NEW YOU : 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	AQ
21-09-17	NEW YOU : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ

Manager	Title	Age	Since
Raymond W. Grimm CEO	Chief Executive Officer	80	2018-07-10
Greg Montoya PSD	President	62	-
James Patrick Sinkes DFI	Director of Finance/CFO	41	-

Director	Title	Age	Since
Nish Mehta BRD	Director/Board Member	59	2018-07-10
Raymond W. Grimm CHM	Chairman	80	2018-07-10

Date	Insider	Type	Main position	Quantity	% Market Cap.
2/5/20	James Patrick Sinkes	Other	Controller/Auditor	110,000	0.3335%
2/5/20	Jared Berry	Other		10,641,107	32.2602%
2/5/20	Gregory Lee Montoya	Other	Chairperson	1,080,000	3.2742%

New You, Inc. Stock

Stocks

NWYU

US6501491079

Pharmaceuticals

Latest news: New You, Inc.

Press Releases: New You, Inc.

Managers and Directors: New You, Inc.

Latest insider transactions

Pharmaceuticals Wholesale

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NEW YOU, INC.	-.--%	-.--%	-	-	16.68K
ELI LILLY AND COMPANY	+3.19%	+11.31%	+64.28%	+155.66%	1,263B
JOHNSON & JOHNSON	-0.73%	+3.56%	+44.65%	+83.74%	658B
ABBVIE INC.	+1.41%	+3.24%	+35.25%	+106.98%	521B
ROCHE HOLDING AG	+0.42%	+3.20%	+55.81%	+69.71%	391B
MERCK & CO., INC.	+2.18%	+2.93%	+73.90%	+45.38%	369B
NOVARTIS AG	+1.12%	+4.52%	+34.76%	+57.00%	307B
ASTRAZENECA PLC	+6.96%	+8.86%	+11.95%	+35.06%	290B
AMGEN INC.	+1.15%	+6.09%	+56.15%	+78.66%	252B
GILEAD SCIENCES, INC.	+3.06%	+9.38%	+42.48%	+112.84%	212B
Average	+1.88%	+5.90%	+46.58%	+82.78%	473.55B
Weighted average by Cap.	+2.01%	+6.60%	+50.51%	+99.19%